Health Ministry notifies ban on Nimesulide for paediatric use
- BJP projected to sweep Gujarat, Rajasthan, Karnataka; Congress to get big jolt in Maharashtra
- Seven-storey building collapses in Mumbai
- John Kerry refuses to comment on Narendra Modi visa issue
- Arvind Kejriwal alleges whole media is sold, backtracks later
- Show us the money, Supreme Court says, refuses bail to Subrata Roy
In its notification on the Central Drug Standard Control organisation website, the Union Health Ministry banned the analgesic nimesulide for paediatric use in India. Satisfied that the use of drug "is likely to involve risks to human beings" the ministry prohibited the manufacture, sale and distribution of the drug.
The ministry also notified the banning of human placenta extract, which is used for wounds, arthritis and other tropical application. Other drugs which have banned on the recommendation of a sub-committee of DTAB are Cisapride — a drug which increases motility in the upper gastrointestinal tract and Phenylepropsalamine — used in cough syrups. Sibutramine and R-Sibutramine — used for losing weight — are also likely to be notified for banning.
Nimesulide is banned for children below 12 years of age, and is not marketed in most countries. Recently, the sub-committee of the government's chief advisory body, Drug Technical Advisory Board, also recommended the ban. The DCGI in a recent meeting instructed drug regulators to be vigilant. "Advertisements may follow to make people cautious," said a ministry official.